Categories: DeliveryDevelopmentBusinessDrugHardwareMedTechSpecialtyTechnology
RDD Pharma Ltd. is a leader in the discovery, development, and commercialization of innovative therapeutics for Ano-rectal diseases.
Investors 2
Funding Rounds 1
Date | Series | Amount | Investors |
16.11.2017 | Series B | $9.5M | - |
Mentions in press and media 2
Date | Title | Description |
16.11.2017 | RDD Pharma Raises $9.5M in Series B Funding | RDD Pharma, a New York and Tel Aviv, Israel-based developer of treatments for lower gastro-intestinal disorders, raised $9.5M in Series B funding.
Backers included new investors Pharmascience and an international life science fund, as well ... |
16.11.2017 | RDD Pharma Raises $9.5M Series B Funding | RDD Pharma, a leader in developing treatments for lower gastro-intestinal disorders, has raised $9.5M in Series B funding, including $6Mfrom two new investors, Pharmascience, Inc. and an international life science fund, as well as existing ... |
Reviews 0